ZYNE
Zynerba Pharmaceuticals Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
at zynerba pharmaceuticals (nasdaq: zyne), we are dedicated to developing next-generation synthetic cannabinoid therapeutics for transdermal delivery for patients with significant unmet medical needs. our mission is to improve the lives of patients battling severe health conditions including refractory epilepsy, osteoarthritis, fragile x syndrome, fibromyalgia and peripheral neuropathic pain through these therapeutics. our development pipeline includes patent-protected synthetic transdermal cannabinoid products, cbd gel – zyn002 and thc pro-drug patch – zyn001, which we believe will provide new treatment options for patients as well as additional treatment options for patients not currently receiving adequate relief or otherwise experiencing intolerable side effects from current treatment regimes.
Market Cap: 70.1 Million
Primary Exchange: NASDAQ
Website: http://zynerba.com/
Shares Outstanding: 53.9 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1542 trading days
From: 2015-08-13 To: 2023-10-10
Lowest Point:
Healthcare tops midday movers
via: SeekingAlpha at 2019-06-11 08:41:05:000
Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...
Healthcare tops midday movers
via: SeekingAlpha at 2019-06-11 08:41:05:000
Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...
Healthcare tops midday movers
via: SeekingAlpha at 2019-06-11 08:41:05:000
Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...
MT, ZYNE among premarket gainers
via: SeekingAlpha at 2019-06-11 05:21:22:000
Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...
MT, ZYNE among premarket gainers
via: SeekingAlpha at 2019-06-11 05:21:22:000
Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...
MT, ZYNE among premarket gainers
via: SeekingAlpha at 2019-06-11 05:21:22:000
Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...
Zynerba nabs new patent in U.S.; shares up 5% premarket
via: SeekingAlpha at 2019-06-11 04:28:17:000
The USPTO has issued Zynerba Pharmaceuticals (NASDAQ: ZYNE ), Patent No. 10,314,792, titled Treatment of Autism Spectrum Disorder with Cannabidiol which includes claims directed to methods of treating autism spectrum disorder by administering a therapeutically effective amo… read more...
Zynerba nabs new patent in U.S.; shares up 5% premarket
via: SeekingAlpha at 2019-06-11 04:28:17:000
The USPTO has issued Zynerba Pharmaceuticals (NASDAQ: ZYNE ), Patent No. 10,314,792, titled Treatment of Autism Spectrum Disorder with Cannabidiol which includes claims directed to methods of treating autism spectrum disorder by administering a therapeutically effective amo… read more...
Zynerba nabs new patent in U.S.; shares up 5% premarket
via: SeekingAlpha at 2019-06-11 04:28:17:000
The USPTO has issued Zynerba Pharmaceuticals (NASDAQ: ZYNE ), Patent No. 10,314,792, titled Treatment of Autism Spectrum Disorder with Cannabidiol which includes claims directed to methods of treating autism spectrum disorder by administering a therapeutically effective amo… read more...
Zynerba Pharmaceuticals: An Updated Investment Thesis
via: SeekingAlpha at 2019-06-10 00:22:50:000
If two men on the same job agree all the time, then one is useless. If they disagree all the time, both are useless . Darryl F. Zanuck Few stocks have been as volatile recently as Zynerba Pharmaceuticals ( ZYNE ) . The shares seem to move five percent or more almost on a… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|